Roche · 4 hours ago
2026 Summer Intern - Regev Lab - Perturbation Modeling
South San Francisco
Internship
Onsite
Intern
$50/hr - $50/hr
Start in 2026 SummerRoche is a leading biotechnology company, and they are seeking a Summer Intern for the Regev Lab focusing on Perturbation Modeling. The role involves developing computational approaches to study biological responses and building models that connect baseline measurements to responses under intervention.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Qualification
Required
Must be pursuing a PhD (enrolled student)
Required Majors: Computer Science, Statistics, Mathematics, Computational Biology, Biostatistics, or a related field
Deep Learning & Python Proficiency: Strong experience with Python and deep learning frameworks (specifically PyTorch). Familiarity with implementing or fine-tuning Transformer architectures and an understanding of generative models is highly desirable
Computational Biology & Single-Cell Analysis: Experience working with single-cell genomic data formats (e.g., AnnData, MuData)
Scientific Communication: Ability to synthesize complex multimodal analysis into clear visualizations and communicate analysis findings
Preferred
Excellent communication, collaboration, and interpersonal skills
Complements our culture and the standards that guide our daily behavior & decisions: Integrity, Courage, and Passion
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
Founded in 1896
10001+ employees
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Alan Hippe
Member of the Executive Board - Group CFO
Christine Bakan
Global Head and Group Vice President, Computational Science and Informatics R&D
Recent News
2026-01-25
2026-01-23
2026-01-22
Company data provided by crunchbase